Address	275 Madison Avenue New York New York 10016 United States
Employees	-
Website	http://www.actiniumpharmaceuticals.com
Updated	07/08/2019
Actinium Pharmaceuticals, Inc. engages in the development of targeted therapies for patients with cancers lacking effective treatment options. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M.